Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate. Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal route is gaining its popularity as a single procedure or adjunctive to th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Department of Surgery, UKM Medical Centre
2013
|
| Online Access: | http://journalarticle.ukm.my/6672/1/09-MS1079_%2828-31%29.pdf |